GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Total Current Assets

Cessatech AS (FRA:8GN) Total Current Assets : €2.62 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cessatech AS Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Cessatech AS's total current assets for the quarter that ended in Sep. 2024 was €2.62 Mil.


Cessatech AS Total Current Assets Historical Data

The historical data trend for Cessatech AS's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Total Current Assets Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Current Assets
1.85 4.10 3.76 1.11

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.11 2.64 2.23 2.62

Cessatech AS Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Cessatech AS's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Cessatech AS's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Cessatech AS  (FRA:8GN) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Cessatech AS's Liquidation Value for the quarter that ended in Sep. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.797-0.618+0.75 * 0+0.5 * 0
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS Total Current Assets Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cessatech AS Business Description

Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines